đź“‹ FDA Reference
kendall sequential compression device huntleigh flowtron venaflow acufex alps sheepskin
Medical Instruments Technology
Summary: The Kendall Sequential Compression Device is used to enhance blood flow in the lower limbs, primarily to prevent deep vein thrombosis (DVT). It is commonly used by healthcare professionals in hospital settings.
FDA Clearance Information
Pathway
510K
Number
K012614 ↗
Decision Date
May 1, 2002
Product Code
JOW
Device Class
Class 2
Evidence
0 studies
The Kendall Sequential Compression Device was cleared through the FDA 510k pathway on May 1, 2002. It is manufactured by Medical Instruments Technology and classified as a Class 2 device.
What It Is
The Kendall Sequential Compression Device is an intermittent pneumatic compression (IPC) device designed to improve venous circulation in the lower limbs. It works by sequentially inflating and deflating air-filled sleeves wrapped around the legs, thereby mimicking the natural muscle contractions that help blood flow. This mechanism is particularly useful in preventing venous stasis and reducing the risk of deep vein thrombosis (DVT) in patients with limited mobility.
Clinical Applications
This device is commonly used in postoperative settings, especially after surgeries that require prolonged immobility, such as orthopedic or abdominal procedures. It is also utilized in intensive care units and for patients with chronic venous insufficiency. The device is beneficial for patients who are at high risk for DVT, including those with a history of thromboembolic events or those undergoing major surgery.
Indications for Use
The FDA indications for this device include enhancing blood flow in the lower limbs to prevent conditions like deep vein thrombosis. It is particularly indicated for patients who are bedridden or have limited mobility due to surgery or other medical conditions.
Practical Considerations
The device comes in various sizes to accommodate different patient needs and is compatible with standard hospital beds. Proper placement and fit of the sleeves are crucial for effective therapy. Clinicians should ensure that the device is used according to the manufacturer's guidelines to maximize patient comfort and therapeutic outcomes.
Related Literature
The linked study compared the effectiveness of a neuromuscular electrostimulation device with two IPC devices, including the Huntleigh Flowtron Universal and the Kendall SCD Express. It found that while all devices enhanced lower limb blood flow, patient tolerance varied. The study highlighted the importance of considering patient comfort and device efficacy when selecting a compression therapy method. However, the study's limitations include a small sample size and the focus on short-term outcomes.
Frequently Asked Questions
What is the Kendall Sequential Compression Device used for?
It is used to enhance blood flow in the lower limbs to prevent deep vein thrombosis, especially in patients with limited mobility.
What specialties typically use this device?
Specialties such as surgery, orthopedics, and critical care commonly use this device in hospital settings.
What are the FDA-cleared indications?
The device is indicated for enhancing blood flow in the lower limbs to prevent conditions like deep vein thrombosis in immobile patients.
Disclaimer: This page compiles publicly available regulatory and published clinical evidence for educational reference.
It does not constitute medical advice, product endorsement, or a recommendation for clinical use.
Always consult manufacturer documentation and clinical judgment for patient care decisions.